tiprankstipranks
Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
Australian Market
AGN
Argenica Therapeutics Ltd
RESEARCH TOOLSreports

Argenica Therapeutics Ltd (AGN) Stock News & Sentiment

13 Followers
Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
Premium
Company Announcements
Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
27d ago
AGN
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
Premium
Company Announcements
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
2M ago
AGN
Argenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
Premium
Company Announcements
Argenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
2M ago
AGN
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
Premium
Company Announcements
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
2M ago
AGN
Argenica Therapeutics Announces Departure of Director Di Angus
Premium
Company Announcements
Argenica Therapeutics Announces Departure of Director Di Angus
3M ago
AGN
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
Premium
Company Announcements
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
3M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
Premium
Company Announcements
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
4M ago
AGN
More AU:AGN News >

AGN News on the Web

Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
TipRanks News
Bearish
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
TipRanks News
Neutral
Argenica Therapeutics And 2 Other ASX Penny Stocks Worth Watching
Simply Wall St
Bullish
Argenica Therapeutics Ltd (AGN) Receives a Buy from Petra Capital
TipRanks News
Bullish
Health Check: Biotech quarterlies serve up sizzling aces amid a few unforced errors
StockHead
Bullish
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
TipRanks News
Neutral
We're Hopeful That Argenica Therapeutics (ASX:AGN) Will Use Its Cash Wisely
Simply Wall St
Neutral
Biocurious: AI becomes the hidden helping hand in clinical trial design and analysis
StockHead
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:AGN’s Media Buzz Sentiment?
Currently, no data Available
What is AU:AGN’s weekly average amount of articles?
Currently, no data Available
What is AU:AGN’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week